$QURE surely a screaming long ahead of AdCom/PDUFA, right?
• FDA softened position on external controls after regime change
• 53% control dropout helps explain 48 month cUHDRS disappointment
• First disease-modifying HD candidate, currently no treatment
Would love to hear your thoughts…
@Lucy3370 Haha yeah, I was confused by your response 😂 Just thinking about how long to hold tbh. Current setup is sell the news before it fades, but could see it going much higher than $100 with time.
@DesertDweller93 Loving your posts, there’s surely no way on earth this doesn’t get approved, right? Three year data with functional capacity as the end point… what am I missing?